ReviewMolecules (Basel, Switzerland)2021

Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer Therapeutics.

John T Isaacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.